05 July 2020: Clinical Research
Suppression of Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Potentiates Cell Apoptosis and Drug Sensitivity to Taxanes and Adriamycin in Breast Cancer
Jie Yu 1ABCDEF , Taobo Jin 2BCDEF , Tianya Zhang 2BCEF*DOI: 10.12659/MSM.922672
Med Sci Monit 2020; 26:e922672
Figure 2 Breast cancer patients with high expression of MALAT1 are associated with worse prognosis as revealed by Kaplan-Meier survival analysis. (A) Kaplan-Meier overall survival curves of MALAT1 of breast cancer. (B1–B3) ROC analysis of predictive efficacy of MALAT1 and molecular typing in breast cancer patients. MALAT1 – metastasis-associated lung adenocarcinoma transcript 1; ROC – receiver operating characteristic.